Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Maria Teresa Lupo Stanghellini
Missing HLA C Group 1 Ligand in Patients With AML and MDS Is Associated With Reduced Risk of Relapse and Better Survival After Allogeneic Stem Cell Transplantation With Fludarabine and Treosulfan Reduced Toxicity Conditioning
American Journal of Hematology
Hematology
Ocular Graft-Versus-Host Disease After Hematopoietic Cell Transplantation: Expert Review From the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
Toxicity and Efficacy of Busulfan and Fludarabine Myeloablative Conditioning for HLA-identical Sibling Allogeneic Hematopoietic Cell Transplantation in AML and MDS
Bone Marrow Transplantation
Transplantation
Hematology
Survival Advantage for Patients With AML and MDS Given Allogeneic Hematopoietic STEM CELL Transplantation Using Myeloablative Versus Reduced Intensity Conditioning (RIC) MAY Become Apparent 5-10 YEARS After Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Pure Red Cell Aplasia After Allogeneic Stem Cell Transplantation With Reduced Conditioning
Bone Marrow Transplantation
Transplantation
Hematology
Long-Term Results of Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-Intensity Conditioning With Busulfan, Fludarabine, and Antithymocyte Globulin
Neoplasma
Cancer Research
Transplant Conditioning With Treosulfan/Fludarabine With or Without TBI. A Randomized Phase II Trial in Patients With MDS and AML
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Monitoring of WT1 Expression in PB and CD34+ Donor Chimerism of BM Predicts Early Relapse in AML and MDS Patients After Hematopoietic Cell Transplantation With Reduced-Intensity Conditioning
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Reduced Toxicity Conditioning With Busulfan, Fludarabine, Alemtuzumab and Allogeneic Stem Cell Transplantation From HLA-Matched Sibling Donors in Children With High Risk Sickle Cell Disease Results in Long Term Donor Chimerism and Low Incidence of aGVHD
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Analysis of Donor and Recipient ABO Incompatibility and Antibody-Associated Complications After Allogeneic Stem Cell Transplantation With Reduced-Intensity Conditioning
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
GvHD-free, Relapse-Free Survival After Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation in Older Patients With Myeloid Malignancies
Bone Marrow Transplantation
Transplantation
Hematology
